FDA issues new warning on misuse of UCB cough drug

03/12/2008 | Yahoo!

The FDA on Tuesday released a new warning on the potentially lethal side effects of misusing Tussionex Pennkinetic Extended-Release Suspension, a cough treatment manufactured by UCB S.A. The agency received reports of health problems and deaths in children and adults who took the drug, which contains hydrocodone, a narcotic pain reliever. "The FDA's alert is fully in line with our efforts to make sure this product is properly used," a UCB spokewoman said.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX